Wednesday, September 2

Browsing: eplontersen

General

CARDIO-TTRansform trial investigating eplontersen fails to meet primary efficacy endpoint

By Healthcare Propulsion StaffAugust 28, 20260

The CARDIO-TTRansform trial investigating eplontersen in patients with transthyretin-mediated amyloid cardiomyopathy did not meet its primary efficacy endpoint, according to…

What's Hot

Coffee’s link to Parkinson’s risk may depend on how your body handles caffeine

Hong Kong woman’s 20-year eating disorder after dad’s death and how she recovered

Certain diabetes patients face higher ketoacidosis risk with SGLT2 drugs

Browsing: eplontersen

CARDIO-TTRansform trial investigating eplontersen fails to meet primary efficacy endpoint

FDA-cleared medical AI rarely tested for real-world benefits

More coffee, higher testosterone? This study found a more complicated picture

This 29-year heart study tracked what happens after smokers quit

New sweating discovery reveals hidden limits of body cooling

Coffee’s link to Parkinson’s risk may depend on how your body handles caffeine

Hong Kong woman’s 20-year eating disorder after dad’s death and how she recovered

Certain diabetes patients face higher ketoacidosis risk with SGLT2 drugs

Researchers found one childhood behavior linked to folic acid use before pregnancy

Our Picks

Coffee’s link to Parkinson’s risk may depend on how your body handles caffeine

Hong Kong woman’s 20-year eating disorder after dad’s death and how she recovered

Subscribe to Updates

What's Hot

Browsing: eplontersen

Subscribe to Updates